- British boxer could face two-year ban from UK Anti-Doping
- ‘Another attempt to create a headline with my name,’ says Benn
UK Anti-Doping (Ukad) has announced that Conor Benn was charged with the alleged use of clomifene, a banned substance that boosts testosterone, this month. The charge could result in a two-year ban for the British boxer who has been trying to resume his troubled career abroad without clearing his name in public first.
This latest development marks a further hardening in Ukad’s approach to the case, which first made news last October when, in the week of his planned and heavily hyped fight against Chris Eubank Jr, it emerged that Benn had returned a positive test result for clomifene. Despite initial efforts to proceed with the bout, the media and public uproar forced its cancellation. Later that month Benn admitted he had also returned a second and earlier positive test result for clomifene. Both these results were recorded by Vada (the Voluntary Anti-Doping Authority) and, while Benn had not failed any Ukad tests, the British agency took serious note of the two separate positives.
Written by Donald McRae
This news first appeared on https://www.theguardian.com/sport/2023/apr/20/conor-benn-was-charged-with-alleged-clomifene-use-in-april-confirms-ukad under the title “Conor Benn was charged with alleged clomifene use in April, Ukad confirms”. Bolchha Nepal is not responsible or affiliated towards the opinion expressed in this news article.
